We aspire to keep the wonderful world visible for all

navigate_next

Capital Markets Day March 16, 2021

About us

Revenio is a global leader in ophthalmological devices. Revenio Group's ophthalmic diagnostic solutions include intraocular pressure measurement devices under the iCare brand, retinal imaging devices and perimeters. The main tools for the detection and diagnosis of glaucoma and its monitoring during treatment are intraocular pressure measurement (tonometry), retinal imaging, and visual field tests (perimetry).

In 2019, the Group's net sales totaled EUR 61.1 million, with its operating profit standing at 28.1%. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.

navigate_next

Annual Report 2020

Revenio has published its Annual Report for 2020

navigate_next

Upcoming event

Q1 interim report will be published on April 23, 2021

navigate_next

IR contacts

CFO Robin Pulkkinen robin.pulkkinen(at)revenio.fi

navigate_next

Share price {{stockPriceLatestDate}}: {{stockPrice}} {{currency}}

Revenio is listed on Nasdaq Helsinki

navigate_next

Analyses

Revenio is followed by Carnegie, Inderes, OP and SEB

navigate_next